This study provides a comprehensive, family-wide analysis of galectins in glioblastoma, revealing that LGALS1, LGALS3, and LGALS9 are consistently overexpressed and strongly associated with adverse survival, immune dysregulation, and tumour-promoting pathways. The gene discussed is LGALS9; the disease is neoplasm.